IDH1 AND IDH2 GENE MUTATIONS ARE FREQUENT MOLECULAR LESIONS IN ACUTE MYELOID LEUKEMIA (AML) AND CONFER ADVERSE PROGNOSIS IN CYTOGENETICALLY NORMAL AML WITH NPM1 MUTATION WITHOUT FLT3-ITD

被引:0
|
作者
Paschka, P. [1 ]
Schlenk, R. [1 ]
Gaidzik, V. [1 ]
Habdank, M. [1 ]
Kroenke, J. [1 ]
Bullinger, L. [1 ]
Spaeth, D. [1 ]
Kayser, S. [1 ]
Zucknick, M. [2 ]
Goetze, K. [3 ]
Horst, H. [4 ]
Germing, U. [5 ]
Doehner, H. [1 ]
Doehner, K. [1 ]
机构
[1] Univ Hosp, Ulm, Germany
[2] German Canc Res Ctr, Div Biostat, D-6900 Heidelberg, Germany
[3] Tech Univ Munich, Univ Hosp, Munich, Germany
[4] Univ Hosp, Kiel, Germany
[5] Univ Hosp, Dusseldorf, Germany
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1108
引用
收藏
页码:456 / 456
页数:1
相关论文
共 50 条
  • [31] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1
    Kim, Hyeoung-Joon
    Kim, TaeHyung
    Kook, Hoon
    Song, Ga-Young
    Ahn, Seo-Yeon
    Jung, Sung-Hoon
    Kim, Mihee
    Yang, Deok-Hwan
    Lee, Je-Jung
    Choi, Seung Hyun
    Kim, Mi Yeon
    Jung, Chul Won
    Jang, Jun-Ho
    Kim, Hee Je
    Moon, Joon Ho
    Sohn, Sang Kyun
    Won, Jong-Ho
    Park, Seong-Kyu
    Kim, Sung-Hyun
    Zhang, Zhaolei
    Ahn, Jae-Sook
    Kim, Dennis Dong Hwan
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 172 - 173
  • [32] IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
    Marcucci, Guido
    Maharry, Kati
    Wu, Yue-Zhong
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Margeson, Dean
    Holland, Kelsi B.
    Whitman, Susan P.
    Becker, Heiko
    Schwind, Sebastian
    Metzeler, Klaus H.
    Powell, Bayard L.
    Carter, Thomas H.
    Kolitz, Jonathan E.
    Wetzler, Meir
    Carroll, Andrew J.
    Baer, Maria R.
    Caligiuri, Michael A.
    Larson, Richard A.
    Bloomfield, Clara D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (14) : 2348 - 2355
  • [33] TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD− mutations
    Xiaopeng Tian
    Yang Xu
    Jia Yin
    Hong Tian
    Suning Chen
    Depei Wu
    Aining Sun
    International Journal of Hematology, 2014, 100 : 96 - 104
  • [34] Prognostic impact of FLT3-ITD, NPM1 mutation and CEBPA bZIP domain mutation in cytogenetically normal acute myeloid leukemia: a Hokkaido Leukemia Net study
    Naoki Miyashita
    Masahiro Onozawa
    Shota Yoshida
    Hiroyuki Kimura
    Shogo Takahashi
    Shota Yokoyama
    Toshihiro Matsukawa
    Shinsuke Hirabayashi
    Shinichi Fujisawa
    Akio Mori
    Shuichi Ota
    Yasutaka Kakinoki
    Yutaka Tsutsumi
    Satoshi Yamamoto
    Takuto Miyagishima
    Takahiro Nagashima
    Makoto Ibata
    Kentaro Wakasa
    Yoshihito Haseyama
    Katsuya Fujimoto
    Toshimichi Ishihara
    Hajime Sakai
    Takeshi Kondo
    Takanori Teshima
    International Journal of Hematology, 2023, 118 : 36 - 46
  • [35] Prognostic impact of FLT3-ITD, NPM1 mutation and CEBPA bZIP domain mutation in cytogenetically normal acute myeloid leukemia: a Hokkaido Leukemia Net study
    Miyashita, Naoki
    Onozawa, Masahiro
    Yoshida, Shota
    Kimura, Hiroyuki
    Takahashi, Shogo
    Yokoyama, Shota
    Matsukawa, Toshihiro
    Hirabayashi, Shinsuke
    Fujisawa, Shinichi
    Mori, Akio
    Ota, Shuichi
    Kakinoki, Yasutaka
    Tsutsumi, Yutaka
    Yamamoto, Satoshi
    Miyagishima, Takuto
    Nagashima, Takahiro
    Ibata, Makoto
    Wakasa, Kentaro
    Haseyama, Yoshihito
    Fujimoto, Katsuya
    Ishihara, Toshimichi
    Sakai, Hajime
    Kondo, Takeshi
    Teshima, Takanori
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (01) : 36 - 46
  • [36] Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)
    Schneider, Friederike
    Hoster, Eva
    Schneider, Stephanie
    Dufour, Annika
    Benthaus, Tobias
    Kakadia, Purvi M.
    Bohlander, Stefan K.
    Braess, Jan
    Heinecke, Achim
    Sauerland, Maria C.
    Berdel, Wolfgang E.
    Buechner, Thomas
    Woermann, Bernhard J.
    Feuring-Buske, Michaela
    Buske, Christian
    Creutzig, Ursula
    Thiede, Christian
    Zwaan, Michel C.
    van den Heuvel-Eibrink, Marry M.
    Reinhardt, Dirk
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    ANNALS OF HEMATOLOGY, 2012, 91 (01) : 9 - 18
  • [37] ACQUIRED MUTATIONS IN THE GENES ENCODING IDH1 AND IDH2 BOTH ARE RECURRENT ABERRATIONS IN ACUTE MYELOID LEUKEMIA (AML): PREVALENCE AND PROGNOSTIC VALUE
    Abbas, S.
    Lugthart, S.
    Kavelaars, F.
    Schelen, A.
    Koenders, J.
    Zeilemakers, A.
    van Putten, W.
    Rijneveld, A.
    Lowenberg, B.
    Valk, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 455 - 455
  • [38] Acute Myeloid Leukemia (AML) with Type A NPM1 Mutation Is More Frequently Associated with FLT3 Mutations Compared with AML with Non-Type A NPM1 Mutations
    Kanagal-Shamanna, R.
    Singh, R. R.
    Routbort, M. J.
    Ravandi, F.
    Kantarjion, H.
    Medeiros, L. J.
    Luthra, R.
    Patel, K. P.
    MODERN PATHOLOGY, 2014, 27 : 354A - 354A
  • [39] ACQUIRED IDH1 AND IDH2 MUTATIONS IN CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKAEMIA: THEIR PREVALENCE AND ASSOCIATION WITH OTHER GENE MUTATIONS - A SINGLE CENTRE EXPERIENCE
    How, G. F.
    Khoo, S. J.
    Tan, L. T.
    Chuah, C.
    HAEMATOLOGICA, 2014, 99 : 307 - 307
  • [40] Prevalence and clinical impact of IDH1 and IDH2 mutations among cytogenetically normal Egyptian acute myeloid leukaemia patients
    Aref, S. E.
    Kamel, E.
    Abou el Naga, A.
    Mohamed, O. A.
    Sabry, M. A.
    Al Biomy, M. A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 85 - 85